The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers.

Trial Profile

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 May 2017

At a glance

  • Drugs Fenofibric-acid (Primary) ; Lopinavir/ritonavir (Primary) ; Ritonavir (Primary)
  • Indications HIV infections; Hyperlipidaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Mar 2012 Lead trial investigator (Scott R Penzak) identified as reported by ClinicalTrials.gov.
    • 08 Feb 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.
    • 03 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top